The estimated Net Worth of Barry J. Regan is at least $6.72 Million dollars as of 8 November 2023. Mr. Regan owns over 2,019 units of Wright Medical NV stock worth over $1,926,215 and over the last 6 years he sold WMGI stock worth over $3,462,418. In addition, he makes $1,327,670 as Senior Vice President and Operations at Wright Medical NV.
Barry has made over 11 trades of the Wright Medical NV stock since 2019, according to the Form 4 filled with the SEC. Most recently he sold 2,019 units of WMGI stock worth $192,249 on 8 November 2023.
The largest trade he's ever made was selling 15,486 units of Wright Medical NV stock on 28 February 2020 worth over $465,354. On average, Barry trades about 1,703 units every 65 days since 2018. As of 8 November 2023 he still owns at least 64,250 units of Wright Medical NV stock.
You can see the complete history of Mr. Regan stock trades at the bottom of the page.
Barry J. Regan serves as Senior Vice President, Operations of the Company. From January 2018 to June 2018, Mr. Regan served as Senior Vice President, Global Supply Chain and Direct Procurement of Smith & Nephew, Inc., a global medical technology company, and served as Senior Vice President, Global Supply Chain of Smith & Nephew, Inc. from March 2015 to December 2017. Prior to joining Smith & Nephew, Inc., Mr. Regan served in two capacities at AbbVie Inc., a biopharmaceutical company; first as Director, Operations Strategy & Network Optimization from September 2011 to September 2012, and then Vice President & General Manager, US & Puerto Rico Manufacturing from September 2012 to February 2015. Prior to joining AbbVie Inc., Mr. Regan served in various positions at Abbott Laboratories, a health care product company, with increasing responsibilities from 1994 to 2011, including most recently Director of Manufacturing Operations. Mr. Regan previously served on the board of directors of the Pharmaceutical Industry Association of Puerto Rico.
As the Senior Vice President and Operations of Wright Medical NV, the total compensation of Barry Regan at Wright Medical NV is $1,327,670. There are 6 executives at Wright Medical NV getting paid more, with Robert Palmisano having the highest compensation of $7,309,180.
Barry Regan is 48, he's been the Senior Vice President and Operations of Wright Medical NV since 2018. There are 19 older and 4 younger executives at Wright Medical NV. The oldest executive at Wright Medical Group NV is Robert Palmisano, 75, who is the President and Chief Executive Officer, Executive Director.
Barry's mailing address filed with the SEC is 6340, Sequence Drive, Sorrento Valley, San Diego, San Diego County, California, 92121, United States.
Over the last 9 years, insiders at Wright Medical NV have traded over $526,674,381 worth of Wright Medical NV stock and bought 118,654 units worth $2,654,459 . The most active insiders traders include Sean Carney, Elizabeth H Weatherman, and Holdings Cooperatief U.A.Wa.... On average, Wright Medical NV executives and independent directors trade stock every 9 days with the average trade being worth of $4,402,563. The most recent stock trade was executed by Tim Lanier on 17 August 2020, trading 951 units of WMGI stock currently worth $28,644.
Wright Medical Group NV engages in the provision of medical device products. It operates through the following segments: U.S. Lower Extremities and Biologics; U.S. Upper Extremities; International Extremities and Biologics; and Corporate. The U.S. Lower Extremities and Biologics includes the sale of its lower extremities products, such as joint implants and bone fixation devices for the foot and ankle; and biologics products used to support treatment of damaged or diseased bone, tendons, and soft tissues or to stimulate bone growth. The U.S. Upper Extremities segment focuses on joint implants and bone fixation devices for the shoulder, elbow, wrist, and hand; and products used across several anatomic sites to mechanically repair tissue-to-tissue or tissue-to-bone injuries, and other ancillary products. The International Extremities and Biologics segment covers all lower and upper extremities products, as well as associated biologics products. The Corporate segment reflects general and administrative expenses not specifically associated with other segments. The company was founded by Frank O. Wright in 1950 and is headquartered in Amsterdam, the Netherlands.
Wright Medical NV executives and other stock owners filed with the SEC include: